Source: Omega Healthcare Investors's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$900.83M
$908.38M
$881.68M
$928.83M
$892.38M
$1.06B
$878.24M
$949.74M
$1.05B
$1.19B
Operating income
$559.95M
$315.17M
$497.59M
$551.75M
—
—
—
—
—
—
Interest expense
$164.10M
$188.76M
$192.46M
$208.72M
$223.39M
$234.60M
$233.24M
$235.53M
$221.72M
$215.03M
Pre-tax income
$384.33M
$105.92M
$296.51M
$343.84M
$162.33M
$416.08M
$436.14M
$255.05M
$428.66M
$624.22M
Income tax
$1.41M
$3.25M
$3.01M
$2.84M
$4.92M
$3.84M
$4.56M
$6.25M
$10.86M
$14.75M
Net income
$366.42M
$100.42M
$281.58M
$341.12M
$159.33M
$416.74M
$426.93M
$242.18M
$406.33M
$590.18M
EBITDA
$827.01M
$602.76M
$778.87M
$853.43M
—
—
—
—
—
—
EPS (basic)
$1.91
$0.51
$1.41
$1.60
$0.70
$1.76
$1.81
$1.01
$1.57
$1.96
EPS (diluted)
$1.90
$0.51
$1.40
$1.58
$0.70
$1.75
$1.80
$1.00
$1.55
$1.94
Diluted shares
201.63M
206.79M
209.71M
222.12M
235.10M
244.34M
244.29M
250.45M
270.45M
304.95M
Operating margin
62.2%
34.7%
56.4%
59.4%
—
—
—
—
—
—
Net margin
40.7%
11.1%
31.9%
36.7%
17.9%
39.2%
48.6%
25.5%
38.6%
49.6%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$93.69M
$85.94M
$10.30M
$24.12M
$163.53M
$20.53M
$297.10M
$442.81M
$518.34M
$27.02M
Goodwill
$643.47M
$644.69M
$643.95M
$644.41M
$651.74M
$651.42M
$643.15M
$643.90M
$643.66M
$644.63M
Total assets
$8.95B
$8.77B
$8.59B
$9.80B
$9.50B
$9.64B
$9.41B
$9.12B
$9.90B
$10.05B
Long-term debt
$4.37B
$4.57B
$4.54B
$5.14B
$5.17B
$5.25B
$5.29B
$5.07B
$4.84B
$4.26B
Total debt
$4.37B
$4.57B
$4.54B
$5.14B
$5.17B
$5.25B
$5.29B
$5.07B
$4.84B
$4.26B
Total liabilities
$4.74B
$4.89B
$4.83B
$5.46B
$5.46B
$5.53B
$5.60B
$5.36B
$5.17B
$4.61B
Shareholders' equity
$3.86B
$3.56B
$3.44B
$4.14B
$3.84B
$3.91B
$3.61B
$3.57B
$4.54B
$5.18B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$624.77M
$577.91M
$499.37M
$553.75M
$708.26M
$722.14M
$625.73M
$617.74M
$749.43M
$878.55M
Capital expenditures
$40.47M
$37.77M
$29.82M
$52.89M
$31.07M
$44.95M
$47.22M
$38.01M
$37.76M
$80.87M
Free cash flow
$584.30M
$540.15M
$469.55M
$500.86M
$677.18M
$677.19M
$578.51M
$579.73M
$711.67M
$797.68M
Investing cash flow
-$1.11B
-$285.13M
-$173.22M
-$378.95M
-$89.06M
-$524.17M
$442.85M
-$770.00K
-$671.16M
-$539.79M
Financing cash flow
$576.30M
-$303.81M
-$410.70M
-$153.96M
-$485.55M
-$341.12M
-$789.45M
-$473.31M
$26.32M
-$838.26M
Dividends paid
$453.15M
$502.60M
$528.70M
$564.13M
$612.31M
$637.65M
$632.89M
$643.87M
$685.45M
$780.39M
Share buybacks
—
—
—
—
—
—
$142.27M
—
—
—
Stock-based compensation
$13.79M
$15.21M
$15.99M
$15.36M
$18.82M
$21.41M
$27.30M
$35.07M
$36.70M
$44.19M
Depreciation & amortization
$267.06M
$287.59M
$281.28M
$301.68M
$329.92M
$342.01M
$332.41M
$319.68M
$304.65M
$325.25M
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$239.32M
$243.30M
$252.75M
$276.03M
$279.32M
$276.79M
$282.51M
$311.59M
$319.22M
$6.66M
$13.99M
$30.76M
Operating income
—
—
—
—
—
—
$281.24M
$310.31M
—
—
$330.91M
$331.69M
Interest expense
$59.43M
$57.82M
$53.97M
$54.69M
$55.24M
$52.28M
$52.90M
$58.12M
$51.74M
$49.76M
$48.12M
$44.54M
Pre-tax income
$61.82M
$71.83M
$118.92M
$111.35M
$118.65M
$114.59M
$147.19M
$191.35M
$171.30M
$159.92M
$379.76M
$85.42M
Income tax
$4.16M
$2.58M
$1.98M
$3.32M
$2.98M
$3.61M
$4.53M
$4.48M
$2.13M
$5.11M
$4.62M
$2.84M
Net income
$55.00M
$67.36M
$113.86M
$111.76M
$113.34M
$109.03M
$136.60M
$179.72M
$164.84M
$151.05M
$362.82M
$83.09M
EBITDA
—
—
—
—
—
—
$361.75M
$392.42M
—
—
$412.76M
$413.72M
EPS (basic)
$0.23
$0.27
$0.46
$0.43
$0.41
$0.34
$0.46
$0.60
$0.55
$0.47
$1.21
$0.27
EPS (diluted)
$0.22
$0.27
$0.45
$0.42
$0.41
$0.33
$0.46
$0.59
$0.55
$0.47
$1.19
$0.27
Diluted shares
2.04M
257.26M
261.53M
275.56M
5.67M
294.93M
303.25M
308.17M
2.79M
315.13M
316.25M
321.01M
Operating margin
—
—
—
—
—
—
99.6%
99.6%
—
—
2365.9%
1078.4%
Net margin
23.0%
27.7%
45.1%
40.5%
40.6%
39.4%
48.4%
57.7%
51.6%
2269.0%
2594.0%
270.2%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$442.81M
$361.77M
$35.19M
$342.44M
$518.34M
$367.96M
$734.18M
$737.19M
$27.02M
$26.15M
$39.04M
$195.90M
Goodwill
$643.90M
$643.78M
$643.79M
$644.59M
$643.66M
$644.06M
$644.89M
$644.64M
$644.63M
$644.35M
$644.44M
$648.55M
Total assets
$9.12B
$9.01B
$8.85B
$9.57B
$9.90B
$9.71B
$10.55B
$10.60B
$10.05B
$10.23B
$10.01B
$10.12B
Long-term debt
$5.07B
$5.03B
$4.66B
$4.86B
$4.84B
$4.45B
$5.00B
$4.99B
$4.26B
—
—
—
Total debt
$5.07B
$5.03B
$4.66B
$4.86B
$4.84B
$4.45B
$5.00B
$4.99B
$4.26B
—
—
—
Total liabilities
$5.36B
$5.31B
$4.95B
$5.17B
$5.17B
$4.77B
$5.36B
$5.35B
$4.61B
$4.78B
$4.37B
$4.36B
Shareholders' equity
$3.57B
$3.51B
$3.71B
$4.21B
$4.54B
$4.74B
$4.99B
$5.04B
$5.18B
$5.19B
$5.39B
$5.51B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$164.98M
$151.47M
$184.10M
$184.88M
$228.97M
$181.95M
$239.26M
$226.71M
$230.62M
$215.50M
$217.72M
$191.02M
Capital expenditures
$14.71M
$6.94M
$7.07M
$8.27M
$15.48M
$20.17M
$12.77M
$21.23M
$26.69M
$8.76M
$17.91M
$24.58M
Free cash flow
$150.27M
$144.53M
$177.03M
$176.62M
$213.49M
$161.78M
$226.50M
$205.48M
$203.93M
$206.74M
$199.81M
$166.44M
Investing cash flow
$111.32M
-$47.45M
-$208.52M
-$133.46M
-$281.73M
$19.26M
-$463.55M
-$83.80M
-$11.71M
-$270.01M
$552.05M
-$156.13M
Financing cash flow
-$389.79M
-$186.02M
-$299.20M
$268.13M
$243.41M
-$347.70M
$588.96M
-$139.05M
-$940.46M
$54.32M
-$639.14M
$4.88M
Dividends paid
$164.57M
$164.76M
$165.96M
$173.28M
$181.45M
$189.22M
$194.57M
$198.21M
$198.39M
$198.42M
$200.03M
$206.95M
Stock-based compensation
$8.76M
$9.23M
$9.19M
$9.08M
$9.20M
$15.81M
$9.23M
$9.28M
$9.87M
$10.59M
$23.45M
$23.69M
Depreciation & amortization
$75.67M
$74.56M
$74.23M
$77.25M
$78.61M
$79.88M
$80.51M
$82.11M
$82.75M
$84.14M
$81.84M
$82.03M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.